Literature DB >> 2020007

Cocaine acts in the central nervous system to inhibit sympathetic neural activity.

V F Raczkowski1, Y M Hernandez, H K Erzouki, T P Abrahams, A K Mandal, P Hamosh, E Friedman, J A Quest, K L Dretchen, R A Gillis.   

Abstract

Cocaine was administered i.v. to decerebrate cats while monitoring cardiac preganglionic sympathetic nerve activity (SNA), arterial blood pressure (BP) and heart rate (HR). Cocaine, 4 mg/kg i.v., reduced SNA by 55 +/- 6%, but did not significantly affect BP or HR. Cocaine, in doses that were ineffective by the i.v. route, was administered into the vertebral artery and produced decreases in SNA, BP and HR in anesthetized cats. Administration of cocaine into the carotid artery was without effect. Topical administration of cocaine to the intermediate area of the ventrolateral medullary surface (25 micrograms/side) evoked hypotension and bradycardia. Nisoxetine, an inhibitor of norepinephrine uptake, applied bilaterally to the intermediate area (30 micrograms/side) exerted a similar hypotensive effect. Lidocaine administered in doses equivalent to those of cocaine had no significant effect on SNA when given i.v. or on BP when given into the vertebral artery. These results indicate that cocaine inhibits central sympathetic outflow and that the site of action appears to be in the hindbrain at a site that is reached by placement of the drug at the intermediate area of the ventrolateral medulla. The data also indicate that the mechanism of action of cocaine to inhibit sympathetic outflow may be unrelated to its local anesthetic action and may involve inhibition of catecholamine uptake in the ventrolateral medulla.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020007

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  2 in total

1.  Effects of intranasal cocaine on sympathetic nerve discharge in humans.

Authors:  T N Jacobsen; P A Grayburn; R W Snyder; J Hansen; B Chavoshan; C Landau; R A Lange; L D Hillis; R G Victor
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline.

Authors:  G Eisenhofer; P Friberg; D S Goldstein; M Esler
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.